论文部分内容阅读
目的探讨应用盐酸氨溴索预防早产儿呼吸窘迫综合征(NRDS)的治疗效果方法入院后给予常规的保暖、吸氧、抗感染等治疗,治疗组入院后即刻使用盐酸氨溴索(杭州澳亚生物技术有限公司生产)30mg/(kg·d),分4次由注射泵给药,注射时间20min,使用1～3d不等结果治疗组发生NRDS10例(9.26%),对照组发生NRDS31例(28.70%),治疗组NRDS发生率明显低于对照组,有显著差异性(P<0.01)结论应用盐酸氨溴索预防早产儿呼吸窘迫综合征疗效确切,副作用小,费用低廉,值得临床推广
Objective To investigate the effect of ambroxol hydrochloride in preventing respiratory distress syndrome (NRDS) in preterm infants.Methods The patients were treated with Ambroxol Hydrochloride immediately after admission Biotechnology Co., Ltd.) 30mg / (kg · d), divided into 4 times by the injection pump, injection time 20min, the use of 1 ~ 3d range Results NRDS 10 cases (9.26%), control group occurred NRDS 31 cases 28.70%). The incidence of NRDS in the treatment group was significantly lower than that in the control group (P <0.01). Conclusion Ambroxol hydrochloride is effective in preventing respiratory distress syndrome in preterm infants with small side effects and low cost, which is worthy of clinical promotion